The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Tissue Microarray Market Projected To Reach By 2030?
The tissue microarray market size has witnessed rapid expansion over recent years. Projections show it will increase from $13.11 billion in 2025 to $14.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The market’s growth during the preceding period was fueled by factors such as the rise in cancer research activities, the growing use of immunohistochemistry techniques, the development of academic pathology research, the increased requirement for biomarker validation tools, and the accessibility of paraffin-embedded tissue samples.
The tissue microarray market size is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $23.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expected growth throughout the forecast period stems from factors such as increasing investments in precision oncology research, the rising adoption of digital pathology solutions, the expansion of translational research initiatives, a growing demand for multi-omics analysis, and the increasing application of tissue microarrays in drug discovery. Prominent trends for this period include the wider use of high-throughput tissue analysis platforms, the rising acceptance of multiplex immunohistochemistry, an increasing demand for standardized tissue arrays, the expansion of automated tissue microarray construction, and enhanced integration with molecular diagnostics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
Which Drivers Are Supporting The Tissue Microarray Market Growth?
The increasing need for personalized medicine is projected to fuel the expansion of the tissue microarray market in the coming years. Personalized medicine involves customizing medical care based on individual traits, leading to more effective and accurate healthcare solutions. Tissue microarrays are employed in personalized medicine to simultaneously examine numerous tissue samples, enabling swift and effective biomarker evaluation for customized patient therapies. An example of this trend is seen in February 2024, when the USFDA gave approval to 16 new personalized treatments for individuals with rare diseases in 2023, as reported by the US-based nonprofit Personalized Medicine Coalition, which is a considerable rise from 6 such treatments in 2022. Consequently, the growing demand for personalized medicine is a key factor propelling the tissue microarray market’s development.
What Are The Key Segment Divisions In The Tissue Microarray Market Segment Structure?
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Immunohistochemistry (IHC)–Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies
3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array
Which Trends Are Expected To Impact The Tissue Microarray Market?
Companies prominent in the tissue microarray market are prioritizing sophisticated solutions, like microarray platforms, to improve the accuracy and effectiveness of high-volume tissue analysis. This technology enables the concurrent examination of numerous genes or other biomolecules on a compact area, aiding genetic and expression investigations. As an illustration, MARGenomics, a medical research institute from hospital del Mar in Spain, introduced the Applied Biosystems GeneChip 3000 Dx v2 in June 2023. This advanced microarray platform received funding from the Carlos III Health Institute (ISCIII) and the European Union’s NextGenerationEU initiative. Notably, it stands as the first microarray platform in both Europe and the United States to gain regulatory approval for diagnostic applications, having secured IVD-R (In Vitro Diagnosis Regulation) certification. The system offers a wide array of capabilities, including genomic and expression microarrays.
Which Organizations Are Engaged In The Tissue Microarray Market?
Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.
Get The Full Tissue Microarray Market Report:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
Which Region Represents The Largest Share Of The Tissue Microarray Market?
North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Tissue Microarray Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
Browse Through More Reports Similar to the Global Tissue Microarray Market 2026, By The Business Research Company
Microarray Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-global-market-report
Dna Microarray Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report
Microarray Scanners Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model